Table 2.
Baseline Characteristics of the ASPIRE-VA Participants in Extended 2nd Year of Treatment by Arm
| Characteristics | ASPIRE-Phone (n = 105) | ASPIRE-Group (n = 115) | MOVE! (n = 112) | p values |
|---|---|---|---|---|
| Age, M (SD) | 56.9 (9.0) | 55.8 (9.4) | 55.3 (10.1) | 0.45 |
| BMI (kg/m2), M (SD) | 35.5 (5.6) | 36.4 (6.0) | 36.5 (6.4) | 0.38 |
| Male (%) | 87 (83.0) | 98 (85.2) | 99 (88.4) | 0.51 |
| Race/ethnicity (%) | ||||
| Black | 43 (41.0) | 50 (43.4) | 42 (37.5) | |
| White | 61 (58.0) | 64 (55.7) | 69 (61.6) | 0.93 |
| Other | 1 (1.0) | 1 (0.9) | 1 (0.9) | |
| Education, years (%) | ||||
| < 13 | 24 (22.9) | 25 (21.7) | 24 (21.4) | |
| 13–16 | 49 (46.7) | 59 (51.3) | 66 (58.9) | 0.29 |
| ≥ 16 | 29 (27.6) | 29 (25.2) | 17 (15.2) | |
| Missing | 3 (2.9) | 2 (1.7) | 5 (4.5) | |
| Income < $20,000 (%)* | 36 (34.3) | 52 (45.2) | 49 (43.8) | 0.10 |
| Health-related disability (%) | 41 (39.0) | 60 (52.2) | 65 (58.0) | 0.01 |
| Charlson Comorbidity Index, M (SD) | 1.1 (1.3) | 1.2 (1.5) | 1.2 (1.6) | 0.11 |
| Depression (%) | 20 (19.0) | 41 (35.7) | 44 (39.3) | 0.003 |
| PTSD (%) | 12 (11.4) | 25 (21.7) | 20 (17.9) | 0.12 |
| Serious mental illness (%) | 6 (5.7) | 4 (3.5) | 8 (7.1) | 0.46 |
| Substance use disorder (%) | 6 (5.7) | 13 (11.3) | 38 (33.9) | <0.001 |
| Diabetes (%) | 34 (32.4) | 48 (41.7) | 40 (35.7) | 0.34 |
| Hypertension (%) | 70 (66.7) | 79 (68.7) | 77 (68.8) | 0.93 |
| Hypercholesterolemia (%) | 48 (45.7) | 68 (59.1) | 55 (49.1) | 0.11 |
| EQ-5D pain (%)† | ||||
| None | 23 (21.9) | 26 (22.6) | 15 (13.4) | |
| Moderate | 67 (63.8) | 73 (63.5) | 78 (69.6) | 0.40 |
| Severe | 12 (11.4) | 15 (13.0) | 17 (15.2) | |
| Site (%) | ||||
| Site 1 | 54 (51.4) | 51 (44.3) | 62 (55.4) | 0.24 |
| Site 2 | 51 (48.6) | 64 (55.7) | 50 (44.6) | |
*20 Patients with missing values
†6 Patients with missing values